
Maravai to Acquire Officinae Bio’s DNA and RNA Business
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services, has announced an agreement to acquire the DNA and RNA business of Officinae Bio. This acquisition…












